Toggle Health Problems and D

Resveratol helps vitamin D bind to cells

Resveratrol Potentiates Vitamin D and Nuclear Receptor Signaling - Dec 2014

Journal of Cellular Biochemistry, DOI: 10.1002/jcb.25070
Angelika Dampf-Stone1,‡, Shane Batie1,2,‡, Marya Sabir1,‡, Elizabeth T. Jacobs3,4, Jamie H. Lee1, G. Kerr Whitfield2, Mark R. Haussler2 and Peter W. Jurutka1,2, pjurutka at asu.edu
1 School of Mathematical and Natural Sciences, Arizona State University, Glendale, AZ 85306
2 Department of Basic Medical Sciences, The University of Arizona, College of Medicine, Phoenix, AZ, 85004
3 University of Arizona Cancer Center, Tucson AZ, 85724
4 Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, 85724

The 1,25-dihydroxyvitamin D3 (1,25D) hormone is derived from vitamin D generated in skin or obtained from the diet, and binds to and activates the vitamin D receptor (VDR) in target tissues including kidney, colon/small intestine, and bone/muscle.
We tested resveratrol for its ability to modulate VDR signaling, using vitamin D responsive element (VDRE) and mammalian two-hybrid (M2H) transcriptional system technology. Via VDRE-based assays in kidney, colon and myoblast cells, VDR-mediated transcription was activated by resveratrol, and a cooperative effect on transactivation was observed with resveratrol plus 1,25D. The M2H assay revealed a modest, resveratrol-induced dimerization of VDR with its retinoid X receptor (RXR) heteropartner.
Cells treated with both resveratrol and 1,25D displayed synergistic stimulation of VDR-RXR heterodimerization, while resveratrol antagonized rexinoid-mediated RXR-RXR homodimerization. Increased transactivation in response to resveratrol was also observed with a subset of other nuclear receptors and their respective cognate responsive elements.
Evaluation of wild-type versus a ligand-binding domain mutant VDR revealed that hormone-responsiveness to 1,25D was severely depressed, while the response to resveratrol was only moderately attenuated.

Moreover, radiolabeled 1,25D-displacement assays demonstrated an increase in VDR-bound 1,25D in the presence of resveratrol.
Thus, resveratrol may affect VDR and other nuclear receptors indirectly, likely via the ability of resveratrol to:

  • 1) potentiate 1,25D binding to VDR,
  • 2) activate RXR, and/or 3) stimulate SIRT1, an enzyme known to deacetylate nuclear receptors.

The results of this study elucidate a possible pathway for crosstalk between two nutritionally derived lipids, vitamin D and resveratrol, both of which converge on VDR signaling.
 Download the PDF from sci-hub via VitaminDWiki

- - - - - - - - - - - -
41 studies referenced this study as of July 2021

  • Regulation of resveratrol biosynthesis in grapevine: new approaches for disease resistance? - 2019
  • Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial - 2018
  • Biological effects of combined resveratrol and vitamin D3 on ovarian tissue - 2017
  • Biological Effects of Vitamin D3 Mediated by the Interaction with VDR in Different Tissues

See also VitaminDWiki

VitaminDwiki updated the following chart due to this and previous Resveratrol studies
Reductions in Vitamin D is.gd/VitDReductions

See also web

Title change caused the visitor count to reset.
There have actually been 8939 visitors to this page since it was originally made

Created by admin. Last Modification: Monday December 13, 2021 00:55:07 GMT-0000 by admin. (Version 28)

Attached files

ID Name Comment Uploaded Size Downloads
15965 Potentiates 2015.pdf admin 24 Jul, 2021 1.11 Mb 352
14539 Resveratrol 2020.pdf admin 07 Nov, 2020 914.35 Kb 406
11065 Resveratrol supplementation, where are we now.pdf admin 19 Dec, 2018 507.45 Kb 721